Craig Coleman
Professor/Pharmacy Practice

Are you Craig Coleman?

How to update your information.
Scholarly Contributions

620 Scholarly Contributions

419
Journal Articles
137
Poster/Presentations
41
Other Scholarly Works
12
Digital and Electronic Media, Social Media, Blog, Podcast, Magazine/Trade Publications
6
Conference Proceedings
5
Book Chapters
Cost-effectiveness of amiodarone for prophylaxis of atrial fibrillation after cardiothoracic surgery.
2006
J A Rancourt, R Gallagher, J Kluger, Craig Coleman, Charles M White, E L Gillespie
Research Type: Journal Article

Cost-effectiveness analysis of combination statin/ezetimibe therapy for the treatment of elevated low-density lipoprotein cholesterol
2005
Effie L Gillespie, Craig Coleman, Charles M White, Kristen A Gryskiewicz
Research Type: Journal Article

Cost-benefit analysis of a pharmacy-managed medication assistance program for hospitalized indigent patients.
2003
P Reddy, Robert Quercia, Craig Coleman, G Gousse
Research Type: Journal Article

Cost-Effectiveness of Universal or Phenotype-Driven Selection of Dual Antiplatelet Treatment in Acute Coronary Syndrome
2013
Craig Coleman
Research Type: Poster/Presentation

Cost-Effectiveness of Universal or Genotype Driven Use of Available Dual Antiplatelet Strategies in Patients with Acute Coronary Syndrome.
2012
Craig Coleman
Research Type: Poster/Presentation

Cost-Effectiveness of Universal and Platelet Reactivity Assay-Driven Antiplatelet Therapy in Acute Coronary Syndrome
2013
Craig Coleman
Research Type: Poster/Presentation

Cost-Effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prophylaxis in Atrial Fibrillation.
2012
Jeffrey Kluger, Robin Pisacane, Craig Coleman, Dan Pham, Moise Anglade, Soyon Lee
Research Type: Poster/Presentation

Cost-Effectiveness of Ranolazine Added to Standard-of-Care Treatment in Patients With Chronic Stable Angina Pectoris.
2014
Brendan Limone, Candice Kohn, M W Parker, Craig Coleman
Research Type: Journal Article

Cost-Effectiveness of Olorofim in Invasive Aspergillosis Patients Lacking Suitable Alternative Treatment Options from a US Payer Perspective. ISPOR 2024, May 2024.
2024
Craig Coleman
Research Type: Poster/Presentation

Cost-Effectiveness of Newer Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Systematic Literature Review
2013
Craig Coleman, Brendan Limone, William L Baker Jr.
Research Type: Poster/Presentation

Cost-Effectiveness of Newer Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Systematic Literature Review
2013
Craig Coleman
Research Type: Poster/Presentation

Cost-Effectiveness of Newer Anticoagulants for Stroke Prevention in Atrial Fibrillation
2013
Craig Coleman, Brendan Limone, William L Baker Jr.
Research Type: Poster/Presentation

Cost-Effectiveness of High-Dose Edoxaban Compared with Adjusted-Dose Warfarin for Stroke Prevention in Non--Valvular Atrial Fibrillation Patients
2016
Charles M White, Elizabeth S Mearns, Craig Coleman, Florence Egri, Elaine Nguyen
Research Type: Journal Article

Cost-Effectiveness of High-Dose Edoxaban Compared to Adjusted-Dose Warfarin for Stroke Prevention in Non-Valvular Atrial Fibrillation Patients.
2016
F Egri, E Nguyen, Craig Coleman, E S Mearns, Charles M White
Research Type: Journal Article

Cost-Effectiveness of Extended Duration Venous Thromboembolism Prophylaxis with Aspirin
2012
Craig Coleman
Research Type: Poster/Presentation

Cost-Effectiveness of Clopidogrel Plus Aspirin for Stroke Prevention in Patients With Atrial Fibrillation in Whom Warfarin Is Unsuitable.
2012
Andrew D Straznitskas, Craig Coleman, Jeffrey Kluger, Diana Sobieraj, Moise Anglade
Research Type: Journal Article

Cost-Effectiveness of Apixaban Compared to Aspirin for Stroke Prevention in Atrial Fibrillation.
2012
Moise Anglade, Soyon Lee, Kelly Hagstrom, Craig Coleman, Joy Meng, Jeffrey Kluger
Research Type: Poster/Presentation

Cost-Effectiveness Models of Pharmacologic Stroke Prevention in Atrial Fibrillation: A Systematic Review of Methods
2012
Craig Coleman
Research Type: Poster/Presentation

Cost-Effectiveness Analysis of Extended Duration Anticoagulation with Rivaroxaban to Prevent Recurrent Venous Thromboembolism.
2014
Craig Coleman, Brendan Limone, S H Mody, E A Nutescu, B K Bookhart
Research Type: Journal Article

Cost effectiveness of ibutilide with prophylactic magnesium in the treatment of atrial fibrillation.
2004
J Kluger, Craig Coleman, J P Tsikouris, M Ziska, P Reddy, Charles M White, J O Chung, J S Kalus, A P Spencer, K W Kenyon
Research Type: Journal Article